SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020250
Filing Date
2024-06-14
Accepted
2024-06-14 06:03:24
Documents
19
Period of Report
2024-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20240613_8k.htm   iXBRL 8-K 37659
2 EXHIBIT 1.1 ex_688368.htm EX-1.1 258325
3 EXHIBIT 5.1 ex_688114.htm EX-5.1 8408
4 EXHIBIT 99.1 ex_688394.htm EX-99.1 9621
9 hinecontact.jpg GRAPHIC 10303
10 hinelogo.jpg GRAPHIC 10567
  Complete submission text file 0001437749-24-020250.txt   541302

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240613.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240613_def.xml EX-101.DEF 11424
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240613_lab.xml EX-101.LAB 15310
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240613_pre.xml EX-101.PRE 11584
22 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240613_8k_htm.xml XML 2853
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 241043007
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)